Intensive Neoadjuvant Chemoradiation Protocol for Locally Advanced Esophageal Cancer: Results in Real Life Population

Neoadjuvant chemoradiotherapy (NCRT) has been shown to increase survival in patients with locally advanced esophageal cancer (EC) compared to surgery alone. A single intensive protocol of NCRT (NP) was previously tested in phase I and II trials at our Center, resulting in encouraging results, thus becoming our standard in trimodality approach. Therefore, the aim of this analysis was to evaluate the efficacy and safety of this NP in the daily...